UK-based biotech Gene Weaver has received $515,000 from the Bill and Melinda Gates Foundation to advance its programmable gene insertion technology for use in mammalian cells. The platform aims to support the development of affordable protein therapeutics for low-and middle-income countries (LMICs). The funding will support further development of the company’s gene editing platform, which is […]
The post Gene Weaver awarded Gates Foundation grant for programmable gene insertion platform appeared first on Pharmafile.
